Phoenix Journal · LEV Testing
Two-pack paints and coatings rely on isocyanates - and that same chemistry makes them one of the most common causes of occupational asthma in Britain. Here is what they do inside the body, and why the ventilation that controls them has to be tested.
On the shop floor
The gun hisses, a fine wet sheen lands on the panel, and for a few seconds the air in the booth carries something you cannot really see.
That barely visible mist is the whole story. When a sprayer lays down a two-pack lacquer, a floor coating or a vehicle refinish, the hardener carries isocyanates - the reactive chemistry that lets the paint cure hard and fast. The droplets and vapour hang in the breathing zone, and the body treats them as a threat long before anyone notices a smell or a cough. Most people who end up sensitised never had a dramatic moment to point to. They simply worked in air that was not properly controlled, day after day, until one morning their chest tightened on the way through the door and never fully let go.
Understanding what isocyanates actually do inside the lungs is the difference between treating extraction as paperwork and treating it as the thing that protects a career. So it is worth walking through the biology, and then through the controls that keep the exposure down where it belongs.
Isocyanates are prized in paint precisely because they are so reactive. The chemical group that makes them useful - it bonds readily with the compounds around it - is the same feature that makes them dangerous in the airway. When you breathe in that mist, the same reactivity that cures a coating starts reacting with the proteins lining your lungs. The body does not see paint. It sees an intruder binding to its own tissue, and in a proportion of people it mounts an immune response that never switches off.
The central risk is respiratory sensitisation. Once the immune system has learned to recognise isocyanates, exposure to even trace amounts can trigger a full asthmatic reaction - chest tightness, wheeze, breathlessness and coughing that can arrive hours after the shift has ended. This is why night-time symptoms that ease at the weekend are such a telling pattern. Sensitisation can follow a single heavy exposure or a slow build-up of small ones, and crucially it is permanent. There is no dose that becomes safe again afterwards. A sensitised sprayer may have to leave the trade entirely, because the concentration that sets off an attack can be far below anything you could smell or see.
Isocyanates are one of the leading causes of occupational asthma in the UK, and occupational asthma is not a mild inconvenience. In severe cases the airway narrowing is life-threatening, and even where it is managed it can mean a lifetime of inhalers, lost earnings and a job the person can no longer safely do.
The lungs get the attention, but isocyanates are aggressive elsewhere too. They irritate the eyes and the throat, and skin contact can cause dermatitis. There is also good evidence that uncontrolled skin exposure can contribute to becoming sensitised in the first place, which is why gloves and coveralls matter even when the obvious hazard is airborne. Splashes to the eyes are painful and can damage the surface of the eye. None of this is exotic - it is the everyday cost of working close to a reactive chemical without the right barriers in place.
Because sensitisation cannot be undone, the whole strategy has to be prevention. The airborne concentration is measured against a workplace exposure limit, and for isocyanates that limit is deliberately low: 0.02 mg/m³ averaged over eight hours, with a short-term limit of 0.07 mg/m³ over fifteen minutes. Those figures sound abstract until you realise how little visible mist it takes to breach them. Meeting the limit is the legal minimum, not a target - with a respiratory sensitiser the duty under COSHH is to reduce exposure as far below the limit as is reasonably practicable.
The first line of defence is engineering control: a properly designed spray booth or a local exhaust ventilation system that captures the mist at source and carries it away from the person doing the work. Extraction is only as good as its current performance, though. Filters clog, fans wear, ducting sags and dampers drift out of position, and a booth that passed on the day it was installed can quietly fall below the airflow it needs. Under COSHH that engineering control has to be examined and tested at suitable intervals, and for most systems that means a thorough examination and test at least every fourteen months by a competent person. Where spraying continues, air-fed respiratory protection with an assigned protection factor suited to the task fills the gap the booth cannot - but it never replaces the ventilation, it backs it up.
There is also a growing expectation across the sector that anyone using products containing diisocyanates completes recognised safe-use training before they pick up the gun, reflecting how seriously the reactive chemistry is now taken. Training changes behaviour - where people stand, when they leave the booth, how they handle a mixed pot - and behaviour is often what decides whether the controls actually work.
Prevention has to be checked against real people, not just airflow readings. For anyone working with isocyanates, health surveillance is a requirement, typically starting with a pre-employment respiratory questionnaire and baseline lung-function testing, then repeating at intervals so that early signs are caught before they become permanent. The point is to spot the first flicker of sensitisation while there is still a chance to remove the person from exposure. Alongside this, biological monitoring - a simple urine test measured against a guidance value of around 1 µmol of isocyanate metabolite per mol of creatinine - shows how much is actually getting into the body, past the booth and the mask, which airborne sampling alone can miss.
Put together, the picture is straightforward. The chemistry is unforgiving and the harm is often irreversible, so the controls have to be genuinely reliable rather than nominally present. That is why the honest questions to ask are practical ones: is the extraction still moving the air it should, is the mask the right one and worn correctly, and would a spirometry test today show any drift from the baseline? Getting the true cost of getting this wrong into focus - the human and the financial - tends to sharpen the answers, and it is worth reading how an occupational health claim actually plays out. The same logic of controlling a respiratory sensitiser at source runs through other trades too, including the fume from soldering and electronics assembly, where a different chemistry produces a strikingly similar duty of care.
Questions
No. Once the immune system has become sensitised to isocyanates, the reaction is permanent, and even very small future exposures can trigger a serious asthmatic response. Removing the person from exposure prevents further attacks and stops the condition worsening, but it does not undo the underlying sensitivity. This is precisely why the emphasis is on preventing sensitisation in the first place rather than managing it afterwards.
Local exhaust ventilation used to control isocyanates must be examined and tested at suitable intervals under COSHH, and for most systems that means a thorough examination and test at least every fourteen months by a competent person. Booths that spray heavily or run continuously may need more frequent checks. Airflow can drift as filters load and fans wear, so a system that once performed well can fall below the level it needs without any obvious sign.
Phoenix Duct Clean · by the numbers
Phoenix examines and tests local exhaust ventilation to HSG258 and COSHH - measured, reported and certificated, UK-wide.